Invistics Introduces Supervised Machine Learning for Hospitals and Health Systems for Real-time Drug Diversion

USA - English

• USA - English

ATLANTA, March 21, 2019 /PRNewswire-PRWeb/ -- Invistics, the leading provider of advanced healthcare inventory visibility and analytics software, today announced that it has introduced its latest software. Amidst the nation's opioid crisis, hospitals now have access to the industry's first proven analytics and Drug Enforcement Administration (DEA) compliant software platform for detecting and stopping drug diversion.

"As many as ten percent of healthcare workers divert from their workplace, and most of these instances of theft go unreported. This is a serious issue for our healthcare systems, jeopardizing patient safety, and leading to large DEA fines for non-compliance," said Tom Knight, CEO of Invistics. "We want to solve that problem in a scalable way, and machine learning is helping us detect drug diversion that would have not otherwise been detected."

The software, backed by the National Institutes of Health (NIH) and now available to all hospitals and health systems, is the first time providers have had access to:

• A proven DEA-compliant software
• A software that eliminates paper from controlled substance tracking programs
• Scientifically proven analytics to detect drug diversion

Invistics is also the first drug diversion software that works with all electronic health records and automated dispensing cabinets.

"This is the first time a drug diversion solution has been offered by a company that doesn't sell hardware, such as automated dispensing cabinets or surgical kitting equipment, or that doesn't expect you to buy their hardware. That is critical when analyzing these big data sets – the more providers we can work with, the more data we can use to establish drug diversion intelligence," added Knight.

Currently, Invistics has a true positive accuracy rate of over 90 percent, meaning nine out of 10 events that the software flags as drug diversion are true instances of missing drugs. One pilot hospital for the NIH grant included Piedmont Athens Regional Medical Center in Georgia, which reported almost immediate success.

"Detecting drug diversion is of the utmost importance here at Piedmont Athens Regional," said Charles Peck, M.D., interim CEO of Piedmont Athens Regional, which serves as the 11-hospital system's east hub. "Using Invistics has helped us detect drug diversion at a level we've never been able to reach previously. The new supervised machine learning capability makes it that much easier for us to detect diversion and better focus on patient care as a result."

To learn more about Invistics, visit http://www.invistics.com

About Invistics

Invistics is the leading provider of cloud-based software solutions for healthcare inventory visibility, providing advanced analytics and actionable insights for hospitals and health systems who want to detect and prevent drug diversion. Invistics' solution, called Flowlytics®, tracks the movement of drugs across the complex supply chain – from the time they are shipped from the wholesaler to a healthcare facility, then each time drugs are moved throughout the hospital and administered to patients.

Atlanta-based Invistics Corporation also provides inventory visibility for manufacturers, distributers, repackagers and controlled substance registrants, helping to reduce inventory costs and compliance risks within a single facility or across the extended enterprise. To learn more, visit http://www.invistics.com

About Piedmont Athens Regional Medical Center

Piedmont Athens Regional Medical Center is one of northeast Georgia's largest not-for-profit hospitals. The 359-bed, acute care hospital joined the Piedmont family on Oct. 1, 2016 – expanding quality health services to the 17-county area it serves. Piedmont Athens Regional features a regional Level II trauma center and Level III neonatal ICU. Founded by physicians in 1919, Piedmont Athens Regional has garnered national acclaim in patient experience, comprehensive cardiac care including open heart and thoracic surgery, orthopedics, neurosciences, minimally invasive surgeries, obstetrics and gynecology, pediatrics and oncology and gastroenterology. Piedmont Athens Regional is proud to be recognized in the U.S. News and World Report's Best Hospital List by state and recognized with an A for The Leapfrog Group's Fall 2018 Hospital Safety Grades. In 2018, Leapfrog also named Piedmont Athens Regional a Top Teaching Hospital - the only hospital in Georgia and one of 53 nationally to earn this designation. For more information about Piedmont Athens Regional, visit piedmont.org/athens.

SOURCE Invistics